We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
MedXY AI/MedXY News/Gastroenterology

Gastroenterology

Ask MedXY AI
What is the latest evidence?Key clinical updatesGuideline changes

Latest news

Evaluating Early Outcomes of Robotic versus Laparoscopic and Open Cholecystectomy in the US: A Nationwide Analysis
GastroenterologyRobotic cholecystectomybile duct injury

Evaluating Early Outcomes of Robotic versus Laparoscopic and Open Cholecystectomy in the US: A Nationwide Analysis

By MedXY|Sep 12, 2026

A national multipayer analysis demonstrates robotic cholecystectomy offers comparable safety to laparoscopic methods while improving key outcomes versus open surgery, signaling maturation of robotic biliary surgery.

Global Hospital Infrastructure and Its Impact on Mortality After Pancreas Surgery: Insights from the Hospital Resource Index
Gastroenterologyglobal healthhospital infrastructure

Global Hospital Infrastructure and Its Impact on Mortality After Pancreas Surgery: Insights from the Hospital Resource Index

By MedXY|Sep 12, 2026

A global study identifies key hospital-level modifiable resources that reduce 90-day mortality after pancreas surgery and introduces a composite Hospital Resource Index to guide improvements beyond surgical volume centralization.

Unveiling Excessive Supragastric Belching in Conclusive GERD: Clinical Insights and Predictors
Gastroenterologyacid exposure timegastro-oesophageal reflux disease

Unveiling Excessive Supragastric Belching in Conclusive GERD: Clinical Insights and Predictors

By MedXY|Sep 12, 2026

Excessive supragastric belching (SGB) occurs in nearly 20% of patients with conclusive gastro-oesophageal reflux disease, contributing significantly to acid exposure time and symptom burden. This multicentre study identifies clinical predic

Antifibrinolytic Agents Enhance Liver Regeneration and Reduce Posthepatectomy Liver Failure: Translational Insights from Mice to Humans
Gastroenterologyliver regeneration

Antifibrinolytic Agents Enhance Liver Regeneration and Reduce Posthepatectomy Liver Failure: Translational Insights from Mice to Humans

By MedXY|Sep 9, 2026

Pharmacological reduction of plasminogen via antifibrinolytic agents accelerates liver regeneration after surgery in mice and decreases posthepatectomy liver failure risk in patients, representing a promising therapeutic approach.

Targeting Retinoic Acid-Driven CD16hiCD177+ Neutrophils in Steroid-Resistant GI-GVHD: A Novel Therapeutic Avenue
Gastroenterologyneutrophils

Targeting Retinoic Acid-Driven CD16hiCD177+ Neutrophils in Steroid-Resistant GI-GVHD: A Novel Therapeutic Avenue

By MedXY|Sep 9, 2026

Retinoic acid-driven expansion of CD16hiCD177+ neutrophils mediates steroid-resistant gastrointestinal graft-versus-host disease (GI-GVHD). Inhibition of the retinoic acid receptor restores steroid sensitivity and improves outcomes in murin

Advancing Vascular Reconstruction in Adult Living Donor Liver Transplantation: Deep Left Hilar Pedicle Isolation with In Situ Umbilical Portion Dissection
Gastroenterologyliving donor liver transplantation

Advancing Vascular Reconstruction in Adult Living Donor Liver Transplantation: Deep Left Hilar Pedicle Isolation with In Situ Umbilical Portion Dissection

By MedXY|Sep 9, 2026

This article reviews a novel surgical technique for adult living donor liver transplantation that enhances vascular reconstruction, significantly reduces hepatic arterial thrombosis, and utilizes the umbilical portion as an autologous graft

Evaluating Quality of Life and Recurrence in Recurrent Diverticulitis: A Prospective Multicenter Study Comparing Colectomy and Observation
GastroenterologyrecurrenceNghiên cứu quan sát

Evaluating Quality of Life and Recurrence in Recurrent Diverticulitis: A Prospective Multicenter Study Comparing Colectomy and Observation

By MedXY|Sep 8, 2026

This multicenter prospective study reveals that colectomy in recurrent sigmoid diverticulitis improves disease-specific quality of life and reduces 1-year recurrence compared to observation, informing surgical decision-making.

Advancing Safe Living Liver Donation: Insights from a New U.S. Transplant Program’s Learning Curve
Gastroenterologysurgical learning curveliver surgery outcomes

Advancing Safe Living Liver Donation: Insights from a New U.S. Transplant Program’s Learning Curve

By MedXY|Sep 7, 2026

A new living donor liver transplant program in the U.S. demonstrates that adult living donor hepatectomy can be safely implemented, with surgical proficiency and donor outcomes improving through accumulated experience.

Evaluating the Posterior Rectus Sheath Flap for Durable Hiatal Augmentation in Complex Paraesophageal Hernia Repair
Gastroenterologyparaesophageal herniasurgical durability

Evaluating the Posterior Rectus Sheath Flap for Durable Hiatal Augmentation in Complex Paraesophageal Hernia Repair

By MedXY|Sep 7, 2026

This study assesses the procedural maturation and midterm durability of the posterior rectus sheath flap (PoRSHA) for hiatal reinforcement in complex paraesophageal hernias, demonstrating favorable recurrence rates and low donor-site morbid

Morphology-Based Surgery for Chronic Pancreatitis: Findings from a Europe-Wide Study and the Case for Unified, Next-Generation Guidelines
GastroenterologyPhẫu thuật gan tụymorphology-based surgery

Morphology-Based Surgery for Chronic Pancreatitis: Findings from a Europe-Wide Study and the Case for Unified, Next-Generation Guidelines

By MedXY|Sep 7, 2026

A Europe-wide prospective study shows wide variation in morphology-based surgery for chronic pancreatitis and no clear outcome advantage from current guideline concordance — underscoring the need for unified, clearer recommendations on rese

Navigating Drug-Induced Liver Injury in Clinical Trials: Insights and Updates from FDA Experts
Gastroenterologydrug-induced liver injuryDILI

Navigating Drug-Induced Liver Injury in Clinical Trials: Insights and Updates from FDA Experts

By MedXY|Sep 7, 2026

Drug-Induced Liver Injury (DILI) remains a pivotal challenge in drug development, with evolving drug modalities and clinical trial designs prompting updated regulatory perspectives from FDA specialists.

Clinical Utility of a 30% Reduction in VCTE-Derived Liver Stiffness Measurement for Identifying Histologic Improvement in Metabolic Dysfunction-Associated Steatohepatitis
Clinical Updatesliver stiffness measurementVCTE

Clinical Utility of a 30% Reduction in VCTE-Derived Liver Stiffness Measurement for Identifying Histologic Improvement in Metabolic Dysfunction-Associated Steatohepatitis

By MedXY|Sep 6, 2026

This review examines the clinical relevance of a ≥30% decrease in VCTE-derived liver stiffness in predicting fibrosis regression in MASH, highlighting modest predictive accuracy and the need for improved biomarkers.

Reevaluating Colorectal Cancer Surveillance in Inflammatory Bowel Disease: The Role of Family History Beyond Early-Onset Cases
Gastroenterologycancer surveillancefamily history

Reevaluating Colorectal Cancer Surveillance in Inflammatory Bowel Disease: The Role of Family History Beyond Early-Onset Cases

By MedXY|Sep 6, 2026

A nationwide cohort study reveals that in IBD patients, colorectal cancer risk increases notably with multiple affected relatives, challenging current guidelines prioritizing early-onset family history for surveillance.

Decoding CPEB3-Regulated Alternative Polyadenylation: A New Genetic Lens on Hepatocellular Carcinoma Prognosis
GastroenterologyAlternative PolyadenylationCPEB3

Decoding CPEB3-Regulated Alternative Polyadenylation: A New Genetic Lens on Hepatocellular Carcinoma Prognosis

By MedXY|Sep 5, 2026

This article explores how genetic variants affect CPEB3-mediated alternative polyadenylation in hepatocellular carcinoma, revealing potential prognostic markers and therapeutic targets to improve patient survival.

Achalasia and Its Differential Impact on Esophageal Squamous Cell Carcinoma and Adenocarcinoma Risk: Insights from a Large Nordic Case-Control Study
GastroenterologyepidemiologyEsophageal Adenocarcinoma

Achalasia and Its Differential Impact on Esophageal Squamous Cell Carcinoma and Adenocarcinoma Risk: Insights from a Large Nordic Case-Control Study

By MedXY|Sep 5, 2026

A comprehensive multinational study reveals that achalasia significantly raises the risk of esophageal squamous cell carcinoma independently, while its association with adenocarcinoma is modest and largely mediated by gastroesophageal reflu

Confocal Laser Endomicroscopy-Guided Exclusion Diet Fails to Improve IBS Symptoms in Controlled Trial
GastroenterologyIrritable Bowel SyndromeConfocal Laser Endomicroscopy

Confocal Laser Endomicroscopy-Guided Exclusion Diet Fails to Improve IBS Symptoms in Controlled Trial

By MedXY|Sep 5, 2026

A randomized controlled crossover trial found that individualized exclusion diets based on confocal laser endomicroscopy (CLE) findings do not significantly improve symptoms in irritable bowel syndrome (IBS) patients compared to sham diets.

Metabolite-Mediated Neurocognitive Revival Following Liver Transplantation: Insights into Cortical Network Reactivation
GastroenterologyNeuroinflammationNeurocognitive Recovery

Metabolite-Mediated Neurocognitive Revival Following Liver Transplantation: Insights into Cortical Network Reactivation

By MedXY|Sep 3, 2026

Liver transplantation facilitates early neurocognitive recovery in end-stage liver disease patients by restoring cortical network activities, with S-methyl-5′-thioadenosine playing a pivotal neuroprotective role through modulating neu

Beyond Cirrhosis: Understanding Major Adverse Liver Outcomes in Alpha-1 Antitrypsin Deficiency Genotypes
Gastroenterologyliver diseaseGenotype risk

Beyond Cirrhosis: Understanding Major Adverse Liver Outcomes in Alpha-1 Antitrypsin Deficiency Genotypes

By MedXY|Aug 31, 2026

Alpha-1 antitrypsin deficiency (AATD) Z-allele carriers, including heterozygotes and homozygotes, exhibit progressively increased risk of adverse liver outcomes, emphasizing the need for early diagnosis and vigilant monitoring.

From Pressure Metrics to Personalized Prognosis: Transforming Risk Assessment in Advanced Chronic Liver Disease
GastroenterologyNon-invasive testsrisk stratification

From Pressure Metrics to Personalized Prognosis: Transforming Risk Assessment in Advanced Chronic Liver Disease

By MedXY|Aug 31, 2026

A shift from static portal pressure thresholds to dynamic, non-invasive risk prediction models offers improved prognostic accuracy for decompensation in advanced chronic liver disease, enabling personalized patient management and better cli

Targeting the CA19-9 Glycan: A Promising CAR T Cell Therapy for Pancreatic and Gastrointestinal Cancers
GastroenterologyCA19-9CAR T-cell therapy

Targeting the CA19-9 Glycan: A Promising CAR T Cell Therapy for Pancreatic and Gastrointestinal Cancers

By MedXY|Aug 29, 2026

CAR T cells targeting the CA19-9 glycan show potent, specific anti-tumor activity in pancreatic and various gastrointestinal cancers, providing new avenues for immunotherapy of hard-to-treat solid tumors.

Prev
2 / 25
1234…25
Next
Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities

Browse by specialty

Open language-specific specialty feeds and department pages.

news6629 articlesCardiology1375 articlesClinical Updates1288 articlesOncology1139 articlesDiabetes & Endocrinology842 articlesNeurology820 articlesPublic Health595 articlesGastroenterology572 articles
Hematology-Oncology
487 articles
Pediatrics484 articles
Internal Medicine444 articles